Viewing Study NCT02465957

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:55 PM
Ignite Modification Date: 2026-01-06 @ 5:41 PM
Study NCT ID: NCT02465957
Status: TERMINATED
Last Update Posted: 2024-05-02
First Post: 2015-06-03
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC)
Sponsor: ImmunityBio, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stage IIIB Merkel Cell Carcinoma View
None Stage IV Merkel Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Merkel Cell Carcinoma View
None Neukoplast View
None NK-92 View
None Natural Killer Cell View
None MCC View
None aNK View